查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424468

生物分解性支架市场：依产品类型、依材料类型、依最终用户、按地区

Biodegradable Stents Market, By Product Type, By Material Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2023年生物分解性支架的全球市场规模为3.889亿美元，预计2023年至2030年复合年增长率为7.2%，2030年将达到6.347亿美元。

报告范围 报告详情
基准年 2022年 2023/2024年市场规模 3.889 亿美元
实际资料 2018-2021 预测期 2023-2030
预测期间 2023/2024 至 2030/2031 年复合年增长率： 7.20% 2030/2031 年预测值 6.347 亿美元
图 1. 2023 年按地区分類的生物分解性支架的全球市场占有率(%)
可生物降解支架市场-IMG1

生物分解性支架市场在更广泛的医疗设备产业中正在迅速发展。生物分解性支架也称为生物可吸收支架，用于治疗冠状动脉疾病和周边动脉疾病。这些支架旨在疏通阻塞的动脉，并在一段时间内逐渐溶解在体内，从而无需永久性金属植入，并且与传统支架相关的併发症风险也会降低。全球可生物分解性支架市场受到多种因素的推动，包括心血管疾病盛行率的上升、技术进步以及对微创手术的偏好。对市场产生影响的另一个因素是对更好、更安全的支架替代传统支架的需求不断增长，传统支架可能导致血栓症和血管再阻塞等长期併发症。此外，人们越来越认识到生物分解性支架的好处，例如它们恢復动脉自然运动和功能的能力，也促进了市场的成长。然而，这些支架的高成本和严格的监管核准程序可能会在一定程度上阻碍市场成长。儘管面临这些挑战，生物分解性支架市场仍具有巨大的成长潜力，并为现有参与者和新参与企业提供了许多机会。市场竞争激烈，主要参与者都专注于研发活动，以推出创新产品并获得竞争优势。由于生物可降解支架在医疗保健领域的日益普及以及人们对其相对于传统支架的优势的认识，生物分解性支架市场的未来看起来充满希望。

市场动态：

全球可生物分解性支架市场的主要驱动因素是人们对微创治疗的日益偏好、全球易患心臟病的老年人口的增加以及冠状动脉疾病和周边动脉疾病盛行率的增加。此外，有利的报销政策和监管部门的核准正在推动生物分解性支架的采用。然而，与传统金属支架相比，生物分解性支架的成本较高以及缺乏长期性能资料是对市场成长产生负面影响的主要因素。

本研究的主要特点

  • 本报告详细分析了全球生物分解性支架市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还强调了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、性能和策略等参数，介绍了全球生物分解性支架市场的主要企业。
  • 本研究涵盖的主要企业包括 Boston Scientific Corporation、Abbott、Kyoto Medical Planning Co., Ltd.、QualiMed、Elixir Medical Corporation、ENDOCOR GmbH、BIOTRONIK SE &Co.KG、Amaranth Medical, Inc. 和 Arterial Remodeling Technologies SA。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球生物分解性支架市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
  • 透过用于分析全球生物分解性支架市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 微创手术的采用率增加
    • 抑制因素
  • 可生物分解性支架高成本
    • 机会
  • 技术进步
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章全球生物分解性支架市场－冠状病毒 (COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球生物分解性支架市场，依产品类型，2018-2030

  • 冠状动脉支架
  • 外周支架

第六章全球生物分解性支架市场，依材料类型，2018-2030

  • 聚合物支架
  • 金属支架

第 7 章 全球生物分解性支架市场，依最终使用者划分，2018-2030 年

  • 医院
  • 专科诊所
  • 门诊手术中心

第八章2018-2030年全球生物分解性支架市场（按地区）

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 南非
  • 中部非洲
  • 北非

第9章 竞争形势

  • Boston Scientific Corporation
  • Abbott
  • Kyoto Medical Planning Co., Ltd.
  • QualiMed
  • Elixir Medical Corporation
  • ENDOCOR GmbH
  • BIOTRONIK SE & Co. KG
  • Amaranth Medical, Inc.
  • Arterial Remodeling Technologies SA

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI1917

The global biodegradable stents size is estimated to be at US$ 388.9 Mn in 2023 and is expected to reach US$ 634.7 Mn by 2030, growing at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 388.9 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 7.20% 2030/2031 Value Projection: US$ 634.7 Mn
Figure 1. Global Biodegradable Stents Market Share (%), by Region, 2023
Biodegradable Stents Market - IMG1

The biodegradable stents market is rapidly evolving within the broader medical devices industry. Biodegradable stents, also known as bioresorbable or bioabsorbable stents, are used in the treatment of coronary artery diseases or peripheral artery diseases. These stents are designed to open up blocked arteries and gradually dissolve in the body over a period of time, eliminating the need for a permanent metallic implant and reducing the risk of complications associated with traditional stents. The global biodegradable stents market is driven by several factors including the rising prevalence of cardiovascular diseases, advancements in technology, and the growing preference for minimally invasive procedures. The market is also influenced by the increasing demand for better and safer alternatives to traditional stents, which can cause long-term complications such as thrombosis and restenosis. Furthermore, growing awareness about the benefits of biodegradable stents, such as their ability to restore the natural movement and function of the artery, is also contributing to the growth of the market. However, the high cost of these stents and the stringent regulatory approval process may hinder the market growth to some extent. Despite these challenges, the biodegradable stents market holds immense potential for growth, with numerous opportunities for existing players and new entrants. The market is characterized by intense competition, with key players focusing on research and development activities to introduce innovative products and gain a competitive edge. The future of the biodegradable stents market looks promising, with increasing adoption in the healthcare sector and growing recognition of their benefits over traditional stents.

Market Dynamics:

The global biodegradable stents market is primarily driven by the growing preference for minimally invasive procedures, rising geriatric population worldwide prone to cardiac ailments, and increasing incidence of coronary and peripheral artery diseases. Additionally, favorable reimbursement policies and regulatory approvals are promoting the adoption of biodegradable stents. However, the high cost of biodegradable stents compared to conventional metallic stents and lack of long-term performance data are the major factors negatively impacting the market growth.

Key Features of the Study:

  • This report provides an in-depth analysis of the global biodegradable stents market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global biodegradable stents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Boston Scientific Corporation, Abbott, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc., Arterial Remodeling Technologies SA.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global biodegradable stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biodegradable stents market

Detailed Segmentation:

  • Global Biodegradable Stents Market Segmentation, By Product Type:
    • Coronary Stents
    • Peripheral Stents
  • Global Biodegradable Stents Market Segmentation, By Material Type:
    • Polymer-based Stents
    • Metallic Stents
  • Global Biodegradable Stents Market Segmentation, By End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
  • Global Biodegradable Stents Market Segmentation, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • Boston Scientific Corporation
    • Abbott
    • Kyoto Medical Planning Co., Ltd.
    • QualiMed
    • Elixir Medical Corporation
    • ENDOCOR GmbH
    • BIOTRONIK SE & Co. KG
    • Amaranth Medical, Inc.
    • Arterial Remodeling Technologies SA.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Biodegradable Stents, By Product Type
    • Market Biodegradable Stents, By Material Type
    • Market Biodegradable Stents, By End User
    • Market Biodegradable Stents, By Geography/Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Growing adoption of minimally invasive procedures
    • Restraints
  • High cost of biodegradable stents
    • Opportunities
  • Technological advancements
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Biodegradable Stents Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Biodegradable Stents Market, By Product Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Coronary Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Peripheral Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Biodegradable Stents Market, By Material Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Polymer-based Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Metallic Stents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Biodegradable Stents Market, By End User, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Biodegradable Stents Market, By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape

  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Kyoto Medical Planning Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • QualiMed
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Elixir Medical Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • ENDOCOR GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BIOTRONIK SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Amaranth Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Arterial Remodeling Technologies SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us